Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. März 2011 06:30 ET | Quelle: Vical Incorporated

Vical to Present at ROTH Growth Stock Conference

SAN DIEGO, March 14, 2011 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company's Senior Vice President and Chief Financial Officer, Jill M. Broadfoot, will present at...
11. März 2011 09:00 ET | Quelle: StemCells, Inc.

StemCells, Inc. Reports Fourth Quarter and Fiscal 2010 Financial Results and Business Highlights

PALO ALTO, Calif., March 11, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
10. März 2011 16:02 ET | Quelle: XOMA Royalty Corporation

XOMA Reports 2010 and Fourth Quarter Financial Results

BERKELEY, Calif., March 10, 2011 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its financial results for the fourth...
10. März 2011 16:00 ET | Quelle: Trius Therapeutics, Inc.

Trius to Present at BIO-Europe Spring 2011

SAN DIEGO, March 10, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will...
10. März 2011 09:57 ET | Quelle: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

SAN DIEGO, March 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) today announced that Linda Smibert, Vice President, Business...
10. März 2011 09:00 ET | Quelle: Aastrom Biosciences, Inc.

Aastrom to Present at ROTH Capital Growth Stock Conference

ANN ARBOR, Mich., March 10, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic...
10. März 2011 08:30 ET | Quelle: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Provides Fourth Quarter and Full Year 2010 Financial Results and Business Unit Updates

Progress Continues in Company's Four Business Units: Urology: Urinary catheter blockage and encrustation trial enrolling patients. Results are expected H2-2011. Hospital Infection:...
10. März 2011 08:30 ET | Quelle: Arbutus Biopharma Corporation

Tekmira Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference

VANCOUVER, British Columbia, March 10, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced...
10. März 2011 08:30 ET | Quelle: Talon Therapeutics, Inc.

New Patent Issued for Talon Therapeutics' Marqibo(R) Expands Disease Coverage to Include Lymphoma, Leukemia and Myeloma

SOUTH SAN FRANCISCO, Calif., March 10, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), today announced the issuance of U.S. patent 7,887,836 B2, which covers compositions and methods...
10. März 2011 08:00 ET | Quelle: Discovery Laboratories, Inc.

Discovery Labs Announces Quarterly Business Update Conference Call

WARRINGTON, Pa., March 10, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call on Tuesday, March 22, 2011, at 10:00 AM EDT. Management will provide a...

Vorherige Seite

Nächste Seite